Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an announcement.
Innovative Pharmaceutical Biotech Limited has announced a further extension of the long stop dates for two subscription agreements involving the issuance of shares to Zhang Biaobing and Chen Jing. The extension, now set to 6 October 2025, allows additional time to fulfill the conditions precedent, ensuring the agreements remain in effect without changes to other terms. This move reflects the company’s ongoing efforts to secure necessary funding and maintain its strategic partnerships, which could influence its market positioning and stakeholder interests.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical products and solutions.
Average Trading Volume: 25,258,310
Technical Sentiment Signal: Buy
Current Market Cap: HK$964.3M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.